APP/PS1 double-transgenic AD mice treated with melatonin exhibited an enhanced expression of AICD accompanied by marked improvements in both spatial learning and memory deficits, possibly due to the induction of AICD SUMOylation by melatonin [918]. The gene discussed is APP; the disease is Alzheimer disease.